Skip to main content

Greenlight Capital

Superinvestor

DME Capital Management, LP

SEC CIK
0001489933
Manager
David Einhorn
Style
Value, Hedge fund
Latest filing
Aug 14, 2026

The latest 13F from Greenlight Capital covers Q2 2026 (filed Aug 14, 2026): 46 long positions worth $3.91B. The top 10 holdings make up 52.8% of the portfolio, and the largest is Green Brick Partners, Inc. (GRBK) at 19.4%. Livermore has 10 filings on Form 13F from this institution, going back to Q1 2024.

Predecessor filersGreenlight Capital Inc

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
7
Est. +$480.9M
Added
11
Est. +$193.0M
Reduced
11
Est. −$168.0M
Sold out
6
Est. −$216.1M

Top 5 holdings

Share of this quarter's portfolio value

  1. GRBKGreen Brick Partners, Inc.
    19.4%$757.8MHistory
  2. FLRFluor Corp
    6.2%$244.1MHistory
  3. CNRCore Natural Resources, Inc.
    4.7%$182.7MHistory
  4. BHFBrighthouse Financial, Inc.
    4.6%$179.9MHistory
  5. ACHCAcadia Healthcare Company, Inc.
    3.3%$130.0MHistory

Share of portfolio

Top 5 holdings and the other 41 positions, by share of portfolio value

  1. GRBK19.4%
  2. FLR6.2%
  3. CNR4.7%
  4. BHF4.6%
  5. ACHC3.3%
  6. Other 41 positions61.8%

Biggest buys

New and added positions, by estimated amount bought

  1. FBINFortune Brands Innovations, Inc.
    +$123.1MNewHistory
  2. VGNTVersigent PLC
    +$95.7MNewHistory
  3. PRMBPrimo Brands Corp
    +$69.0MNewHistory
  4. PYPLPayPal Holdings, Inc.
    +$61.5MNewHistory
  5. WBDWarner Bros. Discovery, Inc.
    +$59.9MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. FBINFortune Brands Innovations, Inc.
    +3.15 pp0.0% → 3.1%History
  2. VGNTVersigent PLC
    +2.45 pp0.0% → 2.4%History
  3. PRMBPrimo Brands Corp
    +1.77 pp0.0% → 1.8%History
  4. PYPLPayPal Holdings, Inc.
    +1.57 pp0.0% → 1.6%History
  5. WBDWarner Bros. Discovery, Inc.
    +1.53 pp0.0% → 1.5%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. VSXYVictoria's Secret & Co.
    −$104.6MSold outHistory
  2. CNCCentene Corp
    −$69.4MReducedHistory
  3. SLMSLM Corp
    −$45.0MSold outHistory
  4. PTONPeloton Interactive, Inc.
    −$43.4MSold outHistory
  5. VSNTVersant Media Group, Inc.
    −$39.8MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. VSXYVictoria's Secret & Co.
    −3.28 pp3.3% → 0.0%History
  2. VSNTVersant Media Group, Inc.
    −1.74 pp3.5% → 1.8%History
  3. SLMSLM Corp
    −1.41 pp1.4% → 0.0%History
  4. PTONPeloton Interactive, Inc.
    −1.36 pp1.4% → 0.0%History
  5. DHTDHT Holdings, Inc.
    −0.89 pp3.0% → 2.1%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$3.91B
+$718.1M (+22.5%) vs. prior quarter
Positions
46
+1 vs. prior quarter
Top 10 concentration
52.8%
Top 10 as share of value
Turnover
10.8%
Q2 2026, one quarter
Average holding period
6.3 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2024), so positions held before then are understated.

13F filings by quarter

10 quarters, going back to Q1 2024. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $3.91B (Q2 2026)

Q1 2024: $2.18BQ2 2024: $2.04BQ3 2024: $2.40BQ4 2024: $1.94BQ1 2025: $1.97BQ2 2025: $2.33BQ3 2025: $2.54BQ4 2025: $2.85BQ1 2026: $3.19BQ2 2026: $3.91B
Q1 2024Q2 2026
13F filings of Greenlight Capital by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 202646$3.91BGRBKFLRCNRvs. Q1 2026SEC
Q1 2026May 15, 202645$3.19BGRBKFLRCNRvs. Q4 2025SEC
Q4 2025Feb 17, 202641$2.85BGRBKFLRCNRvs. Q3 2025SEC
Q3 2025Nov 14, 202537$2.54BGRBKFLRCNRvs. Q2 2025SEC
Q2 2025Aug 14, 202534$2.33BGRBKFLRCNRvs. Q1 2025SEC
Q1 2025May 15, 202533$1.97BGRBKCNRBHFvs. Q4 2024SEC
Q4 2024Feb 14, 202536$1.94BGRBKCNRBHFvs. Q3 2024SEC
Q3 2024Nov 14, 202438$2.40BGRBKCNRBHFvs. Q2 2024SEC
Q2 2024Aug 14, 202439$2.04BGRBKCNRBHFvs. Q1 2024SEC
Q1 2024May 15, 202442$2.18BGRBKBHFKD–SEC

13D and 13G filings

Companies where Greenlight Capital reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

2 companies, largest stake first.

Companies where Greenlight Capital owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
COYACoya Therapeutics, Inc.13G/A9.90%1.65M shares–Feb 14, 20251 filingFeb 14, 2025SEC
DCHDauch Corp13G5.20%12.4M sharesNewAug 14, 20261 filingAug 14, 2026SEC

Latest filings

33 filings on file made by Greenlight Capital or listing it as a reporting person; the latest 20 are shown.

Schedule 13D and 13G filings by Greenlight Capital
CompanyFiled (ET)FormStakeChangeEvent dateFiling
DCHDauch CorpAug 14, 20264:06 PM ET13G5.20%12.4M sharesNewJun 30, 2026SEC
CNRCore Natural Resources, Inc.Feb 14, 20255:30 PM ET13G/A4.80%1.41M shares–Below 5%Dec 31, 2024SEC
COYACoya Therapeutics, Inc.Feb 14, 20254:26 PM ET13G/A9.90%1.65M shares–Dec 31, 2024SEC
GRBKGreen Brick Partners, Inc.Nov 15, 202413D/AOld format–––SEC
GRBKGreen Brick Partners, Inc.Jul 15, 202413D/AOld format–––SEC
TLISTalis Biomedical CorpFeb 14, 202413G/AOld format–––SEC
NBSENeuBase Therapeutics, Inc.Feb 14, 202413G/AOld format–––SEC
COYACoya Therapeutics, Inc.Feb 14, 202413G/AOld format–––SEC
CNRCore Natural Resources, Inc.Feb 14, 202413G/AOld format–––SEC
GRBKGreen Brick Partners, Inc.Jan 4, 202413D/AOld format–––SEC
COYACoya Therapeutics, Inc.Dec 12, 202313GOld format–New–SEC
GRBKGreen Brick Partners, Inc.Dec 12, 202313D/AOld format–––SEC
GRBKGreen Brick Partners, Inc.Dec 5, 202313D/AOld format–––SEC
GRBKGreen Brick Partners, Inc.Sep 11, 202313D/AOld format–––SEC
GRBKGreen Brick Partners, Inc.Sep 8, 202313D/AOld format–––SEC
GRBKGreen Brick Partners, Inc.Aug 4, 202313D/AOld format–––SEC
GRBKGreen Brick Partners, Inc.Jun 30, 202313D/AOld format–––SEC
CNRCore Natural Resources, Inc.Feb 14, 202313G/AOld format–––SEC
TLISTalis Biomedical CorpFeb 14, 202313G/AOld format–––SEC
GRBKGreen Brick Partners, Inc.Aug 5, 202213D/AOld format–––SEC